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Experimental Section 
General: Dry-column flash chromatography (DCFC) was carried out with Merck silica gel 60 (15-40m). Thin layer chromatography (TLC) 
was carried out on precoated silica gel 60 F254 plates. IR spectra were recorded with a Perkin-Elmer FTIR 1725X spectrophotometer. UV 
spectra were recorded with a GBC-Cintra 40 UV-vis spectrophotometer. NMR spectra were recorded with Varian Gemini 200 (1H at 200 
MHz, 13C at 50 MHz) and Brucker Avance 500 (1H at 500 MHz, 13C at 125 MHz) spectrometers. Chemical shifts are mesured in ppm, J in 
Hz. Samples were dissolved in the indicated solvent system, and TMS was used as an internal reference (or DSS in D2O solutions). The 
high-resolution MS spectra were obtained with an Agilent Technologies 6210 TOF LC-MS spectrometer. Reactions induced by microwave 
irradiation were performed in a Milestone MultiSynth microwave multimode oven by using a MonoPREP kit. 
Morphology investigations: Investigations of sample morphology were carried out with SEM, using a JEOL JSM-840A instrument, at an 
acceleration voltage of 30 kV. The samples for investigation of morphology of self-organized stuctures of 7 were prepared by dissolving in 
solution (PhMe, PhMe/i-PrOH (1:1), i-PrOH) at room temperature, 0 ºC, and by heating (2 h) at 50 ºC for PhMe/i-PrOH or 80 ºC for PhMe, 
with (15 min) or without ultrasound stimuli. A drop of 1 mM solution of 7 in PhMe/i-PrOH (1:1, v/v), as well as their solution in individual 
solvents (PhMe or i-PrOH) were deposited on the surface of substrate (Si, Al foil and glass, 10x10 mm) and left during 24 h to slowly 
evaporate in a glass Petri dish (diameter 10 cm) under PhMe atmosphere at the room temperature. The remaining fullerene derivatives 
were investigated under the same conditions on a glass substrate by slow evaporation of a 1 mM solution (PhMe and 1:1 PhMe/i-PrOH 
mixture) at room temperature without ultrasonication. The investigated samples were gold sputtered in a JFC 1100 ion sputter and then 
subjected to SEM observations. 
Antioxidant Activity in vitro: All experiments were performed in triplicate, and the average values were taken. Preparation of liposomal gel 
of fullerene C60 and fullerene bisadducts 4-15. Liposomes were composed of tested compounds and soybean lecithin in a 1:4 ratio. Mesured 
fullerene or fullerene (0.1-1 mg) and fourfold mass of lecithin are solubilized in minimal volume of PhMe under the ultrasound for 1 minute. 
Solvent was evaporated and film of lipid-fullerene complex carefully diluted on vortex with deionized water to the concentration of the 
fullerenic component of 0.02 mg/mL. The final concentration of the pure compound of 0.002 mg/mL was obtained prior to use mixing the 
solution with water in 1:9 ratio.  
FOX reagent preparation. Working FOX reagent was preared by adding 10 mL of Reagent 2 (98 mg of (NH4)2Fe(SO4)2x6H2O (FAS) in 100 
mL of 250mM H2SO4) to 900 mL of Reagent 1 (95 mg of XO-Na salt and 880 mg of 2,6-di-t-butyl-4-methylphenol (BHT) in 900 mL of MeOH) 
giving the final concentrations of 250 µM FAS, 125 µM of XO, 25 mM H2SO4, and 4 mM BHT. The reagent was consumed within 24 h. The 
apsorbance was measured at 560 nm by UV-vis spectrophotometer GBC-Cintra 40 with 90% MeOH as a zero probe. The applicability of the 
method in used range of peroxide concentration was confirmed by preparing standard calibration curve using increasing concentrations of 
TBHP (0-200 µM) incubated with FOX reagent at room temperature for 30 min. Apsobances mesured at 560 nm at the different 
concentrations confirmed linear correlation. 
Sample preparation. The fullerenesomes and vitamin C solutions (0.02 mg/mL) were diluted by nine-fold volume of water to gain 0.002 
mg/mL concentration prior to use (0.050 mL : 0.450 mL of water). The same volume of 200 µM TBHP (obtained by diluting 0.050 mL of 2 
mM TBHP with 0.450 mL of water) was added to the sample and vortexed for 1 min. After 10 min of incubation at room temperature, to an 
aliquot of 0.050 mL of the sample 0.950 mL of FOX reagent was added. Absorbance at 560 nm was determined for each sample after 80 
min of incubation at room temperature. 
Standard probe preparation. The standard probe of TBHP was prepared in the same manner, replacing the sample by the same volume of 
water. The absorbance of the standard probe reffers to the starting (maximum) concentration of the peroxide in sample solution, prior to 
incubation. Difference of absorbances of the standard probe (As) and sample (A) is proportional to the quantity of the consumed peroxide by 
the sample compound. 
Blank probe preparation. The blank probe contained 0.950 mL of FOX reagent and 0.050 mL of water. Apsorbance of the blank probe 
mesured at 560 nm (A0) reffers to the color of the reagent itself in the absence of the peroxide, and all absorbances of the samples and 
standards are diminished by the value of A0 for the calculations of the peroxide concentration. 
General procedures 
a) Synthesis of dibenzyl esters of diglycines by direct N,N'-dialkylation of diamines by benzyl bromoacetate: To an ice-cooled 
solution of diamine (0.043 mol, 1 mol equiv) and TEA (8.70 g, 11.9 mL, 0.086 mol, 2 mol equiv) in DCM (250 mL), solution of BBA (17.9 g, 
13.5 mL, 0.086 mol, 2 mol equiv) in DCM (100 mL), was added dropwise, during 4 h. After additional stirring for 24 h, mixture was washed 
with H2O (3 x100 mL) and then with brine (2 x100 mL), and dried over anh. Na2SO4. The solvent was removed in vacuo and the remaining 
material was purified on a SiO2 column by dry-flash chromatography using below mentioned solvents as eluents.  
b) Benzyl groups removal by catalytic reduction. To a solution of dibenzyl ester of diglycine (1 mmol) in MeOH (50-100 mL) 10% Pd/C 
(10%, w/w) was added and the reaction mixture was hydrogenated at 40 psi H2 over 24 h at room temperature. H2 was evacuated from 
suspension with argon stream. The catalyst was removed by filtration and the solvent was evaporated to dryness, leaving the crude product, 
pure enough for further step. 
1. Dibenzyl-N,N'-(heptane-1,7-diyl)diglycinate (2a) was obtained as a colourless oil (1.77 g, 27%) from 1,7-heptanediamine 1a (2.00 g, 
0.015 mol, 1 mol equiv) and TEA (3.11 g, 4.26 mL, 0.031 mol, 2 mol equiv) in DCM (100 mL) and BBA solution (7.06 g, 4.83 mL, 0.31 
mol, 2 mol equiv in DCM (50 mL)), according to general procedure (a): Eluent: EtOAc. 1H NMR (200 MHz, CDCl3):  = 7.33 (s, 5H, 
CHAr), 5.14 (s, 2H, CH2Bn), 3.42 (s, 2H, CH2Gly), 2.57 (t, J=7.1 Hz, 2H, CH2-NH), 1.90 (s, 1H, NH), 1.57-1.37 (m, 2H), 1.29 ppm (br s, 2H); 
13C NMR (50 MHz, CDCl3):  = 172.12 (C=O), 135.37 (CqAr), 128.27, 128.04 (CHAr), 66.11 (CH2Bn), 50.58 (CH2Gly), 49.20 (CH21), 29.59, 
28.97 (CH24), 26.77 ppm. ESI-TOF-MS: m/z: calc. for [C25H35N2O4+H]+: 427.25913, measured 427.25858; IR (ATR): ṽ = 3388, 3031, 
2935, 2859, 1746, 1656, 1582, 1491, 1456, 1388, 1329, 1218, 1080, 1045, 740, 701 cm-1.  
2. Dibenzyl-N,N'-(octane-1,8-diyl)diglycinate (2b) was obtained as a colourless oil (238 mg, 31%) from 1,8-octanediamine 1b (250 mg, 
1,733 mmol, 1 mol equiv) and TEA (350 mg, 0.48 mL, 3.466 mmol, 2 mol equiv) in DCM (12 mL) and BBA solution (793 mg, 0.54 mL, 
3.466 mmol, 2 mol equiv in DCM (6 mL)), according to general procedure (a): Eluent: EtOAc; 1H NMR (200 MHz, CDCl3):  = 7.30 (s, 
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5H, CHAr), 5.16 (s, 2H, CH2Bn), 3.44 (s, 2H, CH2Gly), 2.58 (t, J=7.1 Hz, 2H, CH2-NH), 1.94 (s, 1H, NH), 1.58-1.38 (m, 2H), 1.28 ppm (br s, 
4H); 13C NMR (50 MHz, CDCl3):  = 172.41 (C=O), 135.57 (CqAr), 128.53, 128.29 (CHAr), 66.40 (CH2Bn), 50.85 (CH2Gly), 49.49 (CH21), 
29.88, 29.28, 27.02 ppm; ESI-TOF-MS: m/z: calc. for [C26H36N2O4+H]+: 441.27478, measured 441.27493; IR (ATR): ṽ = 3339, 3034, 
2927, 2854, 1740, 1668, 1457, 1379, 1343, 1186, 1080, 740, 699 cm-1.  
3. Dibenzyl-N,N'-(nonane1,9-diyl)diglycinate (2c) was obtained as a colourless oil (890 mg, 31%) from 1,9-nonanediamine 1c (1.00 g, 
6.000 mmol, 1 mol equiv) and TEA (1.21 g, 1.66 mL, 12.00 mmol, 2 mol equiv) in DCM (50 mL) and BBA solution (2.74 g, 1.90 mL, 
12.00 mmol, 2 mol equiv in DCM (25 mL)), according to general procedure (a): Eluent: PhMe/EtOAc 1:1; 1H NMR (200 MHz, CDCl3):  = 
7.35 (s, 5H, CHAr), 5.16 (s, 2H, CH2Bn), 3.43 (s, 2H, CH2Gly), 2.58 (t, J=7.0 Hz, 2H, CH2-NH), 2.22 (s, 1H, NH), 1.58-1.38 (m, 2H), 1.27 (br 
s, 5H) ppm; 13C NMR (50 MHz, CDCl3):  = 172.28 (C=O), 135.59 (CqAr), 128.47, 128.22 (CHAr), 66.35 (CH2Bn), 50.78 (CH2Gly), 49.47 
(CH2-NH), 29.82, 29.30, 29.26, 27.02 ppm; IR (ATR): ṽ = 3325, 3062, 3033, 1223, 2852, 1737, 1657, 1578, 1491, 1459, 1393, 1329, 
1182, 1023, 737, 699 cm-1. 
4. Dibenzyl-N,N'-(decane-1,10-diyl)diglycinate (2d) was obtained as a colourless oil (1.49 g, 21.6%) from 1,10-decanediamine 1d (2.50 g, 
0.0145 mol, 1 mol equiv) and TEA (2.93 g, 4.01 mL, 0.029 mol, 2 mol equiv) in DCM (90 mL) and BBA solution (6.65 g, 4.55 mL, 0.029 
mol, 2 mol equiv in DCM (45 mL), according to general procedure (a): Eluent: EtOAc; 1H NMR (200 MHz, CDCl3):  = 7.34 (s, 5H, CHAr), 
5.15 (s, 2H, CH2Bn), 3.43 (s, 2H, CH2Gly), 2.58 (t, J=7.0 Hz, 2H, CH2-NH), 1.89 (br s, 1H, NH), 1.60-1.40 (m, 2H), 1.26 ppm (br s, 6H). 13C 
NMR (50 MHz, CDCl3):  = 172.22 (C=O), 135.48 (CqBn), 128.36, 128.13 (CHBn), 66.20 (CH2Bn), 50.71 (CH2Gly), 49.36 (CH2-NH), 29.77, 
29.22 (2 CH2), 26.93 ppm; IR (ATR): ṽ = 3444, 2976, 2939, 1748, 1473, 1434, 1399, 1217 cm-1; ESI-TOF-MS: m/z: calc. for 
[C28H42N2O4+2H]2+: 235.15668, measured: 235.15656; calc. for [C28H41N2O4+H]+: 469.30608, measured: 469.30540. 
5. Dibenzyl-N,N'-(dodecane-1,12-diyl)diglycinate (2e) was obtained as a colourless oil (1.48 g, 20%) from 1,12-dodecanediamine 1e (3.00 
g, 0.015 mol, 1 mol equiv) and TEA (3.02 g, 4.14 mL, 0.030 mol, 2 mol equiv) in DCM (94 mL) and BBA solution (6.86 g, 4.70 mL, 0.030 
mol, 2 mol equiv in DCM (47 mL)) according to general procedure (a): Eluent: PhMe/EtOAc 1:1; 1H NMR (200 MHz, CDCl3):  = 7.32 (s, 
5H, CHAr), 5.16 (s, 2H, CH2Bn), 3.45 (s,2H, CH2Gly), 2.59 (t, J=7.0 Hz, 2H, CH2-NH), 1.71 (br s, 1H, NH), 1.58-1.38 (m, 2H), 1.26 ppm (br 
s, 8H); 13C NMR (50 MHz, CDCl3):  = 172.41 (C=O), 135.54 (CqAr), 128.49, 128.25 (CHAr), 66.35 (CH2Bn), 50.85 (CH2Gly), 49.51 (CH2-
NH), 29.92, 29.42 (2 CH2), 29.37, 27.08 ppm; IR (ATR): ṽ = 3444, 2976, 2939, 1748, 1473, 1434, 1399, 1217 cm-1; ESI-TOF-MS: m/z: 
calc. for [C28H42N2O4+2H]2+: 235.15668, measured: 235.15656; calc. for [C28H41N2O4+H]+: 469.30608, measured: 469.30540. IR (ATR): 
ṽ = 3327, 3034, 2921, 2851, 1742, 1656, 1577, 1464, 1391, 1215, 1188, 994, 736, 699 cm-1; ESI-TOF-MS: m/z: calc. for 
[C30H46N2O4+2H]2+: 249.17233, measured: 249.17317; calc. for [C30H45N2O4+H]+: 497.33738, measured: 497.33723. 
6. N,N'-(heptane-1,7-diyl)diglycine (3a). Catalytic reduction of dibenzyl ester 2a (1.77 g, 4.15 mmol) yielded diglycine 3a as oil (740 mg, 
72.5%). 1H NMR (200 MHz, D2O):  = 3.62 (s, 2H, CH2Gly), 3.05 (t, J=7.6 Hz, 2H, CH2-NH), 1.82-1.45 (m, 2H), 1.38 ppm (br s, 3H); 13C 
NMR (50 MHz, D2O):  = 173.95 (C=O), 51.64 (CH2Gly), 50.11 (CH2-NH), 30.26 (CH24), 28.00, 27.97 ppm; IR (ATR): 2929, 2854, 2362, 
1620, 1570, 1469, 1375, 1321 cm-1; ESI-TOF-MS: m/z: calc. for [C11H23N2O4+H]+: 247.16523, measured 247.16401; calc. for 
[C11H22N2O4 +Na]+: 269.14718, measured 269.14642. 
7. N,N'-(octane-1,8-diyl)diglycine (3b). Catalytic reduction of dibenzyl ester 2b (238 mg, 0.54 mmol) yielded oilish diglycine 3b (110 mg, 
78%). 1H NMR (200 MHz, D2O):  = 3.58 (s, 2H, CH2Gly), 3.02 (t, J=7.6 Hz, 2H, CH2-NH), 1.80-1.60 (m, 2H), 1.35 ppm ( br s, 4H); 13C 
NMR (50 MHz, D2O):  = 174.46 (C=O), 51.90 (CH2Gly), 50.24 (CH21), 30.59, 28.22, 28.19 ppm; IR (KBr): ṽ = 3026, 2914, 2847, 2362, 
1609, 1573, 1449, 1418, 1320, 1301 cm-1. ESI-TOF-MS: m/z: calc. for [C12H25N2O4+H]+: 261.18088, measured 261.17962; calc. for 
[C12H24N2O4 +Na]+: 283.16283, measured 283.16203. 
8. N,N'-(nonane-1,9-diyl)diglycine (3c). Catalytic reduction of dibenzyl ester 2c (820 mg, 1.80 mmol) yielded oilish diglycine 3c (390 mg, 
79%).1H NMR (200 MHz, D2O):  = 3.58 (s, 2H, CH2Gly), 3.03 (t, J=7.9 Hz, 2H, CH2-NH), 1.82-1.50 (m, 2H), 1.33 (br s, 5H) ppm; 13C 
NMR (50 MHz, D2O):  = 174.20 (C=O), 51.79 (CH2Gly), 50.20 (CH21), 30.79 (CH25), 30.68, 28.24, 28.10 ppm; IR (ATR): ṽ = 3201, 3037, 
2924, 2851, 1621, 1570, 1498, 1466, 1375, 1307, 597 cm-1; ESI-TOF-MS: m/z: calc. for [C13H28N2O4+2H]2+: 138.10191, measured: 
138.10095; calc. for [C13H27N2O4+H]+: 275.19653, measured: 275.19530. 
9. N,N'-(decane-1,10-diyl)diglycine (3d). Catalytic reduction of dibenzyl ester 2d (1.02g, 2.18 mmol) yielded diglycine 3d as a colourless oil 
(500 mg, 79%). 1H NMR (200 MHz, D2O):  = 3.58 (s, 2H, CH2Gly), 3.03 (t, J=7.9 Hz, 2H, CH2-NH), 1.80-1.50 (m, 2H), 1.31 (br s, 6H) 
ppm; 13C NMR (50 MHz, D2O):  = 174.26 (C=O), 51.82 (CH2Gly), 50.26 (CH21), 30.99, 30.81, 28.32, 28.17 ppm; IR (ATR): ṽ = 2922, 
2850, 1741, 1578, 1446, 1392, 1326, 1217 cm-1; ESI-TOF-MS: m/z: calc. for [C14H30N2O42H]2+: 145.10973, measured: 145.10980; calc. 
for [C14H29N2O4+H]+: 289.21218, measured: 289.21100. 
10. N,N'-(dodecane-1,12-diyl)diglycine (3e). Catalytic reduction of dibenzyl ester 2e (480 mg, 0.97 mmol) yielded diglycine 3e as a 
colourless oil (290 mg, 95%). 1H NMR (200 MHz, D2O-susp.):  = 3.53 (s, 2H, CH2Gly), 2.97 (t, J=7.6 Hz, 2H, CH2-NH, overlapped with 
DSS signal on 2.91 (t, J=8.0 Hz)), 1.90-1.52 (m, 2H), 1.29 (br s, 8H) ppm; 13C NMR (50 MHz, D2O-susp.):  = 174.69 (C=O), 52.13 
(CH2Gly), 50.36 (CH21), 31.26, 31.14, 30.90, 28.42 (2 CH2) ppm; IR (ATR): ṽ = 3066, 2920, 2851, 1617, 1576, 1496, 1465, 1440, 1381, 
1321, 1305, 595, 569 cm-1; ESI-TOF-MS: m/z: calc. for [C16H34N2O42H]2+: 159.112538, measured: 159.1258, calc. for [C16H33N2O4+H]+: 
317.24348, measured: 317.24275. 
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Table S1. Visible region absorption bands 400–800 nm of cis-2 bisadducts. 
Compound/R- λ1 /ε λ2 /ε λ3 /ε λ4 /ε λ5 /ε 
5/-(CH2)7- 449 /4900  489 /3200 585 /1100 643 /520 682 /340 
7/-(CH2)8- 447 /4600 484 /2700  575 /860  645 /420 681 /250  
9/-(CH2)9- 442 /5100 484 /3100 570  /1000 643 /460 681/290 
11/-(CH2)10- 447 /4300 483 /2500 572 /830 640 /390 702 /250 
13/-(CH2)12- 446 /5000 483 /3000 570 /900 640 /420 683 /280 
Table S2. Principal visible region absorption bands 400–800 nm of cis-3 bisadducts. 
Compound/R- λ1 /ε λ2 /ε λ3 /ε λ4 /ε λ5 /ε 
6/-(CH2)7- 435 /3800 469 /2300 554 /1300 657 /450 729 /310 
8/-(CH2)8- 434 /2900 465 /2000 555 /900 656 /480 731 /300 
10/-(CH2)9- 430 /3700 466 /2200 550 /1200 657 /410 727 /300 
12/-(CH2)10- 429 /3600 465 /2200 552 /1000 658 /410 724 /300 
Table S3. 1H/13C NMR chemical shifts (δ (ppm), multiplicity, J in Hz) of the non-fullerene moiety of regioisomers  
Regioisomer δ(sp3-Cfull) δ(CH2pyrr) δ (CH2(1,n; 1',n')) δ (CH2)  
cis-1 (C7) 
4 
67.68 
65.36 
4.74d(9.0); 4.55d(9.0); 
3.95d(9.0); 3.43d(9.0)  
66.28; 66.14 
3.25dd(9.5; 13.5); 2.97dd(6.0; 13.5) 
52.74 
1.60-2.20 
27.53; 26.04; 23.60 
cis-2 (C7) 
5 
69.72 
69.47 
4.92dd(11.5; 2.7); 4.36dd(10.5; 
2.7); 3.96d(10.5); 3.55d(11.5) 
69.55; 66.71 
3.83ddd(4.5; 8.5; 12.5); 2.84dt(11.0; 
5.0) 
52.14 
1.70-2.30 
29.60; 28.35; 27.92 
cis-2 (C8) 
7 
67.36 
67.00 
4.54dd(9.0; 1.5); 4.20dd(8.5; 
1.5); 3.44d(8.5); 3.04d(9.0) 
67.33; 65.15 
3.23dt(4.5; 7.0); 2.63br d(11.0) 
51.94 
1.35-2.37 
27.85; 27.49; 22.96 
cis-2 (C9) 
9 
68.67 
67.77 
4.68dd(9.5; 1.5); 4.27dd(9.5; 
1.5); 3.54d(9.5); 3.23d(9.5) 
67.77; 67.63 
3.21dt(4.0; 12.0); 2.67dt(12.0; 4.0) 
54.84 
1.50-2.00 
29.00; 28.78; 27.42; 27.07 
cis-2 (C10) 
11 
67.47 
67.13 
4.44dd(9.0; 1.5), 4.22dd(9.0; 
1.5); 3.44d(9.0); 3.37d(9.0)  
68.25; 67.13 
2.99ddd(4.5; 8.5; 12.5); 2.85ddd(4.5; 
8.5; 13.0) 
52.63 
1.45-2.05 
28.07; 27.83; 27.23; 25.89 
cis-2 (C12) 
13 
66.89 
66.71 
4.04d(9.0); 3.99d(9.0); 
3.69d(9.0); 3.67d(9.0) 
67.69; 67.49 
2.88dt(11.5; 7.0); 2.82dt(11.5; 7.0) 
54.16 
1.42-1.88 
28.22; 28.20; 27.23; 26.96; 26.30 
cis-3 (C7) 
6 
71.47 
67.84 
4.59dd(11.0; 2.5); 4.48dd(10.5; 
2.5); 4.31d(10.5); 3.56d(11.0) 
69.51; 65.08 
3.50ddd(7.0; 8.5; 11.5); 2.81ddd(3.5; 
7.5; 11.5) 
51.58 
1.53-1.95 
28.37; 27.88; 24.38 
cis-3 (C8) 
8 
69.09 
65.58 
4.28d(9.5); 4.27d(9.0); 
3.88d(9.0); 3.18d(9.5) 
68.41; 64.63 
3.15q(6.0); 2.71br d(11.5) 
51.90 
1.01-2.35 
29.56; 28.78; 25.23 
cis-3 (C9) 
10 
69.29 
65.62 
4.37dd(9.5; 1.0); 4.36d(8.5); 
3.81dd(8.5; 1.0); 3.26d(9.5) 
69.07; 66.90 
3.14dt(3.5; 11.5); 2.67dt(11.5; 4.0) 
53.43 
1.28-2.07 
29.13; 28.89; 28.45; 25.13 
cis-3 (C10) 
12 
69.26 
65.79 
4.36dd(9.5; 1.5); 4.35dd (9.5; 
1.5); 3.79d(9.5); 3.36d (9.5) 
68.48; 67.74 
3.01ddd(11.5; 9.5; 4.0); 2.82ddd(11.5; 
5.5; 4.5) 
53.02 
1.42-2.02 
27.52; 27.05; 26.98; 25.73 
eq (C12) 
14 
70.34 
69.68 
69.27 
4.32dd(10.0; 1.5); 4.05s; 3.82s; 
3.73dd(8.5; 1.5) 
68.19; 66.75; 65.41 
CH2(1): 2.95t(5.5); CH2(12): 2.94t(5.5) 
53.34; 51.60 
1.20-1.80 
30.28; 30.25; 29.86; 29.61;28.95; 
28.37; 28.07; 27.27; 26.44; 25.33 
trans-4 (C12) 
15 
70.25 
70.03 
4.55dd(9.0; 2.0); 4.53dd(9.0; 
2.0); 4.09d(9.0); 3.70d(9.0) 
68.88; 65.40 
3.19-3.26m; 2.95dt(12.0; 5.0) 
52.86 
1.05-1.88 
31.23; 30.65; 29.76;28.53; 27.54 
δ range  - 
65-72  
3.0-4.9  
65-70 
2.6-3.8  
51-55  
1.0-2.4  
23-30  
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Table S4. 13C NMR chemical shifts of the fullerene moiety of cis-2 bisadducts relative to literature values 
for the corresponding N-mTEG fulleropyrrolidine bisadduct [1]. 
5 (C7) 7 (C8) 9 (C9) 11 (C10) 13 (C12) (-mTEG)2 
160.18 160.12 159.65 159.82 159.02 158.67* 
155.92 155.35 156.04 155.97 156.11 156.51* 
149.06 149.14 149.15 149.22 149.20 149.28 
148.83** 148.84** 148.85** 148.90** 148.82** 148.86** 
148.80** 148.81** 148.80** 148.86** 148.75** 148.75** 
147.29 147.57 147.49 147.60 147.84* 
146.75 147.17 147.25 
147.49**** 
147.73 
146.61** 
146.78*** 
147.73** 147.70** 147.69** 147.66** 
146.50 146.70 147.03 147.06 147.42 147.49* 
146.50 146.65 146.80 146.84 146.93 147.10 
146.15 146.65 146.64 146.81 146.83 146.92 
145.98 146.36 146.39 146.48 146.43 146.48 
145.83 146.31 146.02 146.15 146.08 146.11 
145.70 146.09 145.79 145.99 145.69 145.76 
145.37 145.78 145.64 145.73 145.66 145.69 
145.09 145.46 145.41 145.53 145.61 145.52 
145.02 145.24 145.19 145.26 145.27 145.38 
144.67 145.14 145.14 145.23 145.12 145.11 
144.57 144.60 144.74 144.72 144.76 144.86 
144.12 144.53 144.67 144.68 144.58 144.52 
144.12 144.12 144.19 144.22 144.37 144.48 
143.92 144.02 144.07 144.14 144.13 144.21 
143.92 144.01 144.01 144.06 144.00 144.03 
142.71 143.10 143.10 143.19 142.97 142.92 
141.72 141.53 141.54 141.58 141.56 141.63 
140.73 140.82 140.86 140.90 140.89 140.96 
137.71 138.66 138.89 138.91 138.83 138.76 
133.11 133.87 133.45 133.70 133.80 133.86 
132.46 133.05 132.13 132.59 132.91 133.21 
129.40** 130.68** 129.20** 130.08** 129.56** 129.34** 
* Signals of the sp2 fullerene carbons adjacent to functionalized 6,6-bond. 
** Carbon signals of the relative intensity 1 (the others are the relative intensity 2). 
*** Carbon signal of the relative intensity 3 (2+1). 
**** Carbon signal of the relative intensity 4 (2+2). 
mTEG - triethylene glycol mono methyl ether, CH2CH2OCH2CH2OCH2CH2OCH3 
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Table S5. 13C NMR chemical shifts of the fullerene moiety of bridged cis-1, cis-3, eq i trans-4 bisadducts relative to literature values for the 
corresponding N-mTEG fulleropyrrolidine bisadducts [1]. 
cis-1 cis-3 eq trans-4 
4 (C7) (-mTEG)2 6 (C7) 8 (C8) 10(C9) 12 (C10) -(mTEG)2- 14 (C12) -(mTEG)2- 15 (C12) 
-
(mTEG)2- 
151.97 152.21* 154.70 153.89 153.78 153.68 152.00* 159.21 159.20* 154.14 154.85* 
151.42 151.26* 150.10 149.14 149.67 149.81 150.18* 154.54 153.78* 153.43 152.79* 
150.20 150.58* 148.85 148.93 149.01 149.03 149.12 153.36 153.23* 152.13 151.55* 
149.01 149.08 148.21 148.45 148.53 148.56 148.94* 152.51 152.79* 150.64** 150.90* 
148.10 148.20 148.13 148.10 148.25 148.27 148.75 149.60** 149.80** 150.03 150.85** 
147.05 147.46 147.85 147. 75 148.06 148.06 148.15 148.77 148.85 149.04** 149.52** 
146.89 147.14 147.43 147.71 147.78 147.80 147.57 148.05 148.02 148.89 149.22 
146.41 146.47 146.64 146.79 146.91 146.96 147.14 147.63** 147.75** 148.57 148.26 
146.19** 146.22 146.46 146.52 146.43 146.28 146.29 147.49 147.75 148.17 147.97 
146.15 146.14** 146.03 146.15 146.20 146.21 146.05 147.49 147.26 147.10** 147.64** 
145.55 145.59 146.02 145.94 146.05 146.05 145.89 147.31 147.20 146.76 147.51 
145.37 145.42 145.75 145.86 145.94 145.95 145.85 147.12 146.75 145.99 146.22 
145.07 145.15 145.72 145.59 145.67 145.69 145.66 145.94 146.62 145.92 146.10 
144.64 145.14 145.53 145.57 145.65 145.59 145.54 145.70 145.71 145.83 146.08 
144.26 144.70 144.88 144.96 145.12 145.17 145.34 145.12 145.13 145.62 145.50 
144.08 144.35 144.79 144.84 144.95 144.94 145.18 144.97 144.98 145.57 145.01 
144.02 144.15 144.68 144.61 144.75 144.77 144.76 144.59 144.66 144.40 144.98 
143.81  144.10 142.20 142.97 142.11 143.06 142.35 144.51 144.60 144.02 144.66 
143.22 143.86 142.14 142.03 142.10 142.09 142.31 144.32 144.37 142.81** 142.84** 
143.09 143.06 141.98 142.02 141.93 142.08 141.86 143.48     143.66 142.32 142.58 
142.78** 142.82** 141.50 142.01 141.86 142.06 141.75 143.26 143.20 142.08 142.13 
142.46 142.48 141.43 141.66 141.68 141.59 141.46 142.24 142.30 141.72 141.74 
142.42** 142.48** 139.63 139.69 139.73 139.75 139.80 141.54 141.71 141.34 141.71 
142.37 142.43 138.31 138.11 138.24 138.26 138.56 141.48 141.56 141.29 141.38 
142.05 142.06 135.94 136.98 137.14 137.27 136.88 141.15 141.45 141.16 141.21 
141.74 141.78 134.62 135.36 134.95 134.98 135.18 140.91 140.68 138.75 139.09 
140.84 140.85 134.45 134.59 134.20 133.95 134.17 138.88 139.16 138.48 138.60 
137.99** 137.96** 130.70 130.03 130.49 130.59 130.54* 136.58 136.73 136.09 136.07 
135.18  135.30      135.70 135.52 135.49 135.41 
134.96 135.15        131.19 131.18 
* Signals of the sp2 fullerene carbons adjacent to functionalized 6,6-bond. 
** Carbon signals of the relative intensity 1 (the others are the relative intensity 2). 
mTEG - triethylene glycol mono methyl ether, CH2CH2OCH2CH2OCH2CH2OCH3 
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NMR spectra of compound 2b. 
BnOOC N N COOBn
H H
8  
 
 
9 
 
NMR spectra of compound 2c 
BnOOC N N COOBn
H H
9  
 
 
10 
 
NMR spectra of compound 2d 
BnOOC N N COOBn
H H
10  
 
 
11 
 
NMR spectra of compound 2e 
BnOOC N N COOBn
H H
12  
 
 
12 
 
NMR spectra of compound 3a 
HOOC N N COOH
H H
7  
 
 
13 
 
NMR spectra of compound 3b 
HOOC N N COOH
H H
8  
 
 
14 
 
NMR spectra of compound 3c 
HOOC N N COOH
H H
9  
 
 
15 
 
NMR spectra of compound 3d 
HOOC N N COOH
H H
10  
 
 
16 
 
NMR spectra of compound 3e 
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NMR spectra of compound 4 
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NMR spectra of compound 5 
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NMR spectra of compound 6 
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NMR spectra of compound 7 
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NMR spectra of compound 8 
 
 
 
22 
 
NMR spectra of compound 9 
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NMR spectra of compound 10 
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NMR spectra of compound 11 
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NMR spectra of compound 12 
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NMR spectra of compound 13 
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NMR spectra of compound 14 
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NMR spectra of compound 15. 
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Figure S1: SEM images of the self-organized particles of 7 prepared from different solvents on various substrates at room  
temperature: PhMe (a: glass substrate, d: Al foil, g: Si wafer), PhMe/i-PrOH (b: glass substrate, e: Al foil) and i-PrOH 
(c: glass substrate, f: Al foil) 
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Figure S2. Self-organized particles of 7 obtained from PhMe solution (left) and from 
PhMe/i-PrOH (1:1) mixture (right) at different temperatures. 
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Figure S3. SEM images of flaked microparticles of 7 obtained from PhMe solution (left) 
and from PhMe/i-PrOH (1:1) mixture (right) without (a, b) or with (c, d) ultrasound stimuli. 
 
 
 
Figure S4. SEM images of cis-2 bisadduct 9 (left) and cis-3 bisadduct 12 prepared from  
PhMe solution on glass substrate. 
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 Table S6: Antioxidant capacity of bisadducts 4-15 determined as a percentage of scavenged peroxide. Results are 
also presented relative to vitamin C and pristine C60 as standards. The last two columns present efficiencies relative to 
vitamin C and C60 recalculated to the molar ratio 1:1. 
H2O2 TBHP 
Compound ∆ (%) ∆/∆vitC ∆/∆C60 
∆/∆vitC 
 
M/Mvit
∆/∆C60  
M/MC60 
∆ (%) ∆/∆vitC ∆/∆C60 
∆/∆vitC 
 
M/MvitC
∆/∆C60  
M/MC60 
4, cis-1, n=7 -17.3 1.3 0.9 6.6 1.1 -16.7 1.4 1.0 7.2 1.2 
5, cis-2, n=7 -22.5 1.6 1.2 8.2 1.5 -19.3 1.6 1.2 8.2 1.5 
6, cis-3, n=7 -17.5 1.3 0.9 6.6 1.1 -16.7 1.4 1.0 7.2 1.2 
7, cis-2 n=8 -22.4 1.7 1.2 8.5 1.5 -22.3 1.9 1.3 9.9 1.6 
8, cis-3, n=8 -18.7 1.4 1.0 7.1 1.3 -20.6 1.8 1.2 9.2 1.5 
9, cis-2, n=9  -17.7 1.3 0.9 6.9 1.2 -16.1 1.4 1.0 7.3 1.3 
10, cis-3, n=9 -13.5 1.0 0.7 5.2 0.9 -11.0 0.9 0.7 5.0 0.9 
11, cis-2, n=10 -16.8 1.2 0.9 6.6 1.2 -14.9 1.3 0.9 6.8 1.2 
12, cis-3, n=10 -11.2 0.8 0.6 4.3 0.8 -10.2 0.9 0.6 4.8 0.8 
13, cis-2, n=12 -16.3 1.2 0.8 6.6 1.1 -15.6 1.1 0.7 6.0 1.0 
14, eq, n=12 -12.0 0.9 0.6 5.0 0.8 -11.5 1.0 0.6 5.4 0.9 
15, trans-4, n=12 -11.3 0.8 0.6 4.4 0.8 -8.94 0.8 0.5 4.2 0.7 
C60 -19.0 1.4 1.0 5.7 1 -16.7 1.4 1 5.8 1 
Vitamin C -13.7 1.0 0.7 1 0.2 -11.7 1 0.7 1 0.2 
